China Rejects Espionage Claims Involving Nvidia C.E.O. Jensen Huang

U.S. consumer prices seen rising 3.8% year-on-year in October - Truflation

Investing.com · News 11m ago

Zura Bio’s tibulizumab fails phase 2 trial for skin disease

Investing.com · News 11m ago

Atea Pharmaceuticals secures $200M credit facility from Hercules

Investing.com · News 11m ago

Spruce Biosciences plans spinoff of CAH drug program

Investing.com · News 11m ago

Can-Fite reports patient cancer-free 10 years after trial

Investing.com · News 11m ago

Crisis mundial del vino obliga a los viñedos chilenos a reinventar sus negocios

Bloomberg · Markets Video 11m ago

Faeth reports phase 2 trial results for endometrial cancer drug

Investing.com · News 11m ago

Brady adds two directors to board, one retires

Investing.com · News 11m ago

Basic Materials Roundup: Market Talk

Dow Jones · Markets 12m ago

Affiliated Managers earnings beat by $0.71, revenue fell short of estimates

Investing.com · News 12m ago